The PE ratio for Phibro Animal Health stock stands at 30.24 as of Jun 5, 2025. This is calculated based on the current EPS of $0.79 and the stock price of $23.89 per share. A decrease of 70% has been recorded in the P/E ratio compared to the average of 100.7 of the last 4 quarters.
Over the last ten years, the average PE ratio of Phibro Animal Health has been 28.88. The current 30.24 PE ratio is 4.7% above the historical average. In the past ten years, PAHC's PE ratio was at its highest in the Jun 2024 quarter at 279.5, with a price of $16.77 and an EPS of $0.06. The Jun 2016 quarter recorded the bottom point at 8.84, with a price of $18.66 and an EPS of $2.11.
Maximum annual increase: 1,552.87% in 2024
Maximum annual decrease: -64.81% in 2016
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 279.5 | 1,552.87% | $16.77 | $0.06 |
2023 | 16.91 | 6.96% | $13.7 | $0.81 |
2022 | 15.81 | -26.64% | $19.13 | $1.21 |
2021 | 21.55 | -31.91% | $28.88 | $1.34 |
2020 | 31.65 | 34.51% | $26.27 | $0.83 |
2019 | 23.53 | -17.73% | $31.77 | $1.35 |
2018 | 28.6 | 25.82% | $46.05 | $1.61 |
2017 | 22.73 | 157.13% | $37.05 | $1.63 |
2016 | 8.84 | -64.81% | $18.66 | $2.11 |
2015 | 25.12 | N/A | $38.94 | $1.55 |
2014 | N/A | N/A | $21.95 | -$0.1 |
2013 | N/A | N/A | N/A | $0.82 |
2012 | N/A | N/A | N/A | $0.23 |
2011 | N/A | N/A | N/A | -$0.19 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 27.04 | -38.19% | $21.36 | $0.79 |
Dec 2024 | 43.75 | -16.46% | $21 | $0.48 |
Sep 2024 | 52.37 | -81.26% | $22.52 | $0.43 |
Jun 2024 | 279.5 | 613.37% | $16.77 | $0.06 |
Mar 2024 | 39.18 | 25.18% | $12.93 | $0.33 |
Dec 2023 | 31.3 | 27.44% | $11.58 | $0.37 |
Sep 2023 | 24.56 | 45.24% | $12.77 | $0.52 |
Jun 2023 | 16.91 | -21.64% | $13.7 | $0.81 |
Mar 2023 | 21.58 | 44.83% | $15.32 | $0.71 |
Dec 2022 | 14.9 | 28.89% | $13.41 | $0.9 |
Sep 2022 | 11.56 | -26.88% | $13.29 | $1.15 |
Jun 2022 | 15.81 | 14.9% | $19.13 | $1.21 |
Mar 2022 | 13.76 | -11.74% | $19.95 | $1.45 |
Dec 2021 | 15.59 | -13.15% | $20.42 | $1.31 |
Sep 2021 | 17.95 | -16.71% | $21.54 | $1.2 |
The current PE ratio of PAHC is greater than its 10-year historical average, but it is lower than the 3 and 5-year averages.
PAHC's PE ratio is lower than its peer stock LLY, but it is greater than MRK's and ZTS's. Phibro Animal Health's current PE ratio of 30.24 is comparable to the average of its peer group, which is 30.07.
Stock name | PE ratio | Market cap |
---|---|---|
MRK Merck & Co Inc | 11.49 | $198.72B |
ADM Archer-Daniels-Midland Co | 16.91 | $22.83B |
PAHC Phibro Animal Health Corp | 30.47 | $975.64M |
ZTS Zoetis Inc | 30.5 | $75.77B |
LLY ELI LILLY & Co | 62.4 | $729.76B |
ICCC Immucell Corp | N/A | $60.37M |
PAHC stock has a price to earnings ratio of 30.24 as of Jun 5, 2025.
Over the last 3 years, the average price to earnings ratio for PAHC stock is 48.21.
Over the last 5 years, the average price to earnings ratio for PAHC stock is 36.81.
In the last ten years, the Jun 2024 quarter recorded the highest quarterly PE ratio at 279.5.
The current price to earnings ratio of PAHC is 4.7% higher than the 10-year historical average.
To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (Jun 5, 2025), Phibro Animal Health's stock price is $23.89. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.79. Therefore, Phibro Animal Health's P/E ratio for today is 30.24. PE RATIO(30.24) = STOCK PRICE($23.89) / TTM EPS($0.79)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.